Anlotinib is an oral multi-target tyrosine kinase inhibitor used as an antineoplastic agent in the treatment of non-small cell lung cancer and metastatic colorectal cancer. This category contains a comprehensive… Read more
![Chemical structure of 1-[[[4-[[4-Fluoro-2-methyl-3-(phenylmethyl)-1H-indol-5-yl]oxy]-6-methoxy-7-quinolinyl]oxy]methyl]cyclopropanamine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2205042-80-2-1-4-4-Fluoro-2-methyl-3-phenylmethyl-1H-indol-5-yloxy-6-methoxy-7-quinolinyloxymethylcyclopropanamine.png&w=3840&q=75)








Anlotinib is an oral multi-target tyrosine kinase inhibitor used as an antineoplastic agent in the treatment of non-small cell lung cancer and metastatic colorectal cancer. This category contains a comprehensive range of high-quality reference standards designed to support rigorous pharmaceutical analysis. These materials include the active pharmaceutical ingredient, alongside related substances such as synthesis impurities, degradation products, and process-related byproducts like quinolinyl dimers and des-methyl derivatives. Analytical laboratories utilize these reference materials for impurity profiling, method development, and validation during stability testing. Additionally, the collection features stable isotope labelled compounds, such as deuterium-labelled variants, which serve as internal standards for accurate quantification in liquid chromatography-mass spectrometry (LC-MS) assays. These essential tools assist in maintaining quality control and compliance standards throughout the drug development and manufacturing lifecycle of the therapeutic compound.